Cosmos Health Inc. (NASDAQ:COSM) Sees Large Drop in Short Interest

Cosmos Health Inc. (NASDAQ:COSM) saw a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 363,500 shares, a decline of 36.1% from the October 15th total of 568,500 shares. Based on an average trading volume of 487,900 shares, the short-interest ratio is presently 0.7 days. Approximately 2.0% of the shares of the company are sold short.

Cosmos Health Price Performance

Shares of Cosmos Health stock traded down $0.02 during trading hours on Friday, hitting $0.63. The company’s stock had a trading volume of 132,921 shares, compared to its average volume of 837,910. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.17 and a current ratio of 1.35. Cosmos Health has a 12-month low of $0.47 and a 12-month high of $1.65. The business has a 50 day moving average price of $0.83 and a two-hundred day moving average price of $0.90. The company has a market cap of $14.65 million, a PE ratio of -0.28 and a beta of 5.72.

Cosmos Health (NASDAQ:COSM) last released its earnings results on Tuesday, August 20th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.14) by $0.05. The firm had revenue of $13.21 million during the quarter, compared to analysts’ expectations of $15.25 million. Cosmos Health had a negative return on equity of 5.83% and a negative net margin of 38.19%. Analysts expect that Cosmos Health will post -0.48 earnings per share for the current fiscal year.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.